NCT03171194View on ClinicalTrials.gov

Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

October 25, 2018

Conditions
System; Lupus Erythematosus
Interventions
DRUG

Low Dose Mesenchymal Stem Cells (MSCs)

Mesenchymal stromal/stem cells (MSCs) are cells that can be derived from umbilical cords, bone marrow, adipose tissue, and dental pulp, among other sites. MSCs have the ability to mediate a range of immuno-modulatory actions for both the innate and adaptive immune systems.

Trial Locations (2)

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03171194 - Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter